Such treatments can alter the protein expression of Bax, caspases, Bcl-2, MAPK, NF-κB, VEGF, DNA methylation, and CDK inhibitor and induce changes in the cell cycle and the CRC cellular functions of adhesion, migration, and invasion. This evidence concerns the gene NFKB1 and colorectal carcinoma.